Biotech API manufacturing services market includes contract manufacturing services for the production of biotechnology-based active pharmaceutical ingredients (API). The biotech APIs include manufacture of active ingredients from animal, microbial, human, or genetically engineered origin by biological techniques. Several dynamics in the biotechnology field are influencing the manufacturing and development strategies of companies in the market. Presently, these dynamics are favoring the growth of biotech API manufacturing services market. The market is very emerging compared to mature chemically synthesized APIs manufacturing services market. However, biotech APIs manufacturing services have high growth potential in the near future owing to increasing demand for biotechnology products.
The global biotech active pharmaceutical ingredients (API) manufacturing market is segmented as monoclonal antibody manufacturing, mammalian cell culture manufacturing, recombinant proteins production, insulin analogues manufacturing, growth hormone API manufacturing, interferon manufacturing, and vaccine manufacturing. The mammalian cell culture manufacturing services segment garnered maximum revenues in the global biotech active pharmaceutical ingredient (API) services market. Increasing applications of monoclonal antibodies (mAbs) and development of next-generation antibody therapies such as antibody-drug conjugates are expected to boost the market in the near future. 
Smaller biotech companies with intellectual property rights for novel biologics will further drive the biopharmaceutical API manufacturing services market. As the contract manufacturing services companies have expertise and economies of scale in these operations, the reduced cost and higher quality product can be transferred to client biotech companies enabling them to focus more on research and development of novel biologics.
Geographically, the global market for the biotech API manufacturing services is segmented into four major regions namely, North America, Europe, Asia- Pacific and Rest of the World. According to report from the Chemical Pharmaceutical Generic Association, the growth of biotech active pharmaceutical ingredient (API) services markets in emerging markets has increased compared to established markets. The reason cited for the phenomenal growth in these countries is their ability to reduce the cost of development for innovative APIs thereby providing competitive edge in the market. 
China and India are expected to grow at rate thrice that of in the Western Europe. Furthermore, improvements in the trade relationship and cooperation between Taiwan and China, Taiwanese biotech companies are contributing to the global growth of biotech active pharmaceutical ingredient (API) services market. The global companies in the biotechnology market are also selling their manufacturing plants for several purposes such as:
  • To remove assets from their balance sheets
  • Focusing on specializing and expediting the research and development activities
  • Used existing resources for other projects thereby saving tremendous resources cost
  • Reduce risks in the supply chain by distributing the manufacturing in varied locations
  • Increase quality assurance and regulatory management
Some of the key players in the global biotech active pharmaceutical ingredients (API) manufacturing services market include AbbVie Contract Manufacturing (part of AbbVie, Inc.), Biogen Idec International GmbH, Bristol-Myers Squibb Co., Boehringer Ingelheim BioXcellence (part of Boehringer Ingelheim Pharma GmbH & Co KG), Biocon Ltd., Celltrion, Inc., Cytovance Biologics, Inc., DSM Biologics, Eden Biodesign Ltd. (Elona Biotechnologies, Inc.(part of Zimmerman Biotechnologies), Fujifilm Diosynth Biotechnologies UK Ltd., Gallus Biopharmaceuticals, LLC, GSK Biopharmaceuticals, Hexal Arzneimittel (part of Novartis),  kSep Systems (part of KBI Biopharma), Lonza Group Ltd., Novo Nordisk, Piramal Healthcare, Protalix BioTherapeutics, Inc., Samsung BioLogics Co. Ltd., and Wave Biotech (part of GE Healthcare).

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Biotech Api Manufacturing Services

Pre Book